Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086–107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsieh RW, Go RS, Abeykoon JP, Kapoor P, Kumar SK, Gertz MA, et al. Characteristics of long-term survivors with multiple myeloma: a National Cancer Data Base analysis. Cancer. 2019;125:3574–81.

Article  PubMed  Google Scholar 

Kumar SK, Dispenzieri A, Fraser R, Mingwei F, Akpek G, Cornell R, et al. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time. Leukemia. 2018;32:986–95.

Article  CAS  PubMed  Google Scholar 

Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23:3412–20.

Article  PubMed  Google Scholar 

Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33:2863–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pawlyn C, Davies FE. Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood. 2019;133:660–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Zhang J, Diao L, Han L. Small non-coding RNAs in human cancer: function, clinical utility, and characterization. Oncogene. 2021;40:1570–7.

Article  CAS  PubMed  Google Scholar 

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.

Article  CAS  PubMed  Google Scholar 

Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004.

Article  PubMed  PubMed Central  Google Scholar 

Handa H, Murakami Y, Ishihara R, Kimura-Masuda K, Masuda Y. The role and function of microRNA in the pathogenesis of multiple myeloma. Cancers. 2019;11:1738.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Federico C, Sacco A, Belotti A, Ribolla R, Cancelli V, Giacomini A, et al. Circulating microRNAs and their role in multiple myeloma. Noncoding RNA. 2019;5:37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood. 2017;129:2429–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li F, Hao M, Feng X, Zang M, Qin Y, Yi S, et al. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma. Leuk Res. 2015;39:793–9.

Article  PubMed  Google Scholar 

Wu P, Agnelli L, Walker BA, Todoerti K, Lionetti M, Johnson DC, et al. Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol. 2013;162:348–59.

Article  CAS  PubMed  Google Scholar 

Papadimitriou M-A, Papanota A-M, Adamopoulos PG, Pilala K-M, Liacos C-I, Malandrakis P, et al. miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome. Br J Cancer. 2022;126:79–90.

Article  CAS  PubMed  Google Scholar 

Martens-Uzunova ES, Olvedy M, Jenster G. Beyond microRNA-novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett. 2013;340:201–11.

Article  CAS  PubMed  Google Scholar 

Yang H, Beutler B, Zhang D. Emerging roles of spliceosome in cancer and immunity. Protein Cell. 2022;13:559–79.

Article  CAS  PubMed  Google Scholar 

Grewal SS. Why should cancer biologists care about tRNAs? tRNA synthesis, mRNA translation and the control of growth. Biochimica et Biophysica Acta. 2015;1849:898–907.

Article  CAS  PubMed  Google Scholar 

Liang J, Wen J, Huang Z, Chen XP, Zhang BX, Chu L. Small nucleolar RNAs: insight into their function in cancer. Front Oncol. 2019;9:587.

Article  PubMed  PubMed Central  Google Scholar 

Chu A, Robertson G, Brooks D, Mungall AJ, Birol I, Coope R, et al. Large-scale profiling of microRNAs for The Cancer Genome Atlas. Nucleic Acids Res. 2016;44:e3.

Article  PubMed  Google Scholar 

Dvinge H, Guenthoer J, Porter PL, Bradley RK. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. Genome Res. 2019;29:1591–604.

Zahoor M, Westhrin M, Aass KR, Moen SH, Misund K, Psonka-Antonczyk KM, et al. Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss. Blood Adv. 2017;1:2656–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mjelle R, Sellæg K, Sætrom P, Thommesen L, Sjursen W, Hofsli E. Identification of metastasis-associated microRNAs in serum from rectal cancer patients. Oncotarget. 2017;8:90077–89.

Article  PubMed  PubMed Central  Google Scholar 

Aass KR, Nedal TMV, Tryggestad SS, Haukås E, Slørdahl TS, Waage A, et al. Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma. Sci Rep. 2022;12:12147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrews S. A quality control tool for high throughput sequence data. 2019. https://www.bioinformatics.babraham.ac.uk/projects/fastqc/.

MARTIN M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10–12.

Article  Google Scholar 

Hannon GJ. FASTX-Toolkit. 2010. http://hannonlab.cshl.edu/fastx_toolkit.

Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–9.

Article  CAS  PubMed  Google Scholar 

Law CW, Chen Y, Shi W, Smyth G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29.

Article  PubMed  PubMed Central  Google Scholar 

Kryukov F, Nemec P, Radova L, Kryukova E, Okubote S, Minarik J, et al. Centrosome associated genes pattern for risk sub-stratification in multiple myeloma. J Transl Med. 2016;14:150.

Article  PubMed  PubMed Central  Google Scholar 

Mjelle R, Sjursen W, Thommesen L, Saetrom P, Hofsli E. Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location. BMC Cancer. 2019;19:161.

Article  PubMed  PubMed Central  Google Scholar 

Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, Darb-Esfahani S, et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS ONE. 2012;7:e51862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hagen P, Zhang J, Barton K. High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions. Blood Cancer J. 2022;12:83.

Article  PubMed  PubMed Central  Google Scholar 

Toden S, Goel A. Non-coding RNAs as liquid biopsy biomarkers in cancer. Br J Cancer. 2022;126:351–60.

Article  CAS  PubMed  Google Scholar 

Chen D, Yang X, Liu M, Zhang Z, Xing E. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma. Cancer Gene Ther. 2021;28:1256–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agnelli L, Bisognin A, Todoerti K, Manzoni M, Taiana E, Galletti S, et al. Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing. Blood Cancer J. 2019;9:21.

Article  PubMed  PubMed Central  Google Scholar 

Shi W, Hendrix D, Levine M, Haley B. A distinct class of small RNAs arises from pre-miRNA-proximal regions in a simple chordate. Nat Struct Mol Biol. 2009;16:183–9.

Artic